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1. INTRODUCTION 2. EXPERIMENTAL 
The involvement of Na+,K+-ATPase in the ino- 
tropic effect of ouabain in rat heart remains con- 
troversial ([l-6]. A sustained positive inotropic 
effect has been observed in vivo with 10-8-10-7 M 
ouabain [l-5], whereas inhibition of the enzyme in 
vitro was detectable only at 10-5-10-4 M [1,2]. In 
Cat+-free perfused rat heart, Na+,K+-ATPase ac- 
tivity was reported inhibited by therapeutic doses 
of ouabain (IO-* M) [6]; this enzyme form was 
undetectable in non-perfused heart [6]. Thus, it 
appears that there is a close parallel at similar drug 
doses between the positive inotropic effect and 
Na+,K+-ATPase inhibition. In vivo, K+ interfered 
with the effects of ouabain. In the rat, K+ did not 
affect the development of the inotropic response, 
but markedly lowered its amplitude [4]. In an at- 
tempt to correlate the enzyme form highly sensitive 
to ouabain with the physiological site responsible 
for the inotropic effect, we investigated the role(s) 
of K+ on the enzyme activity. We report here that 
potassium (10mM) does not affect the low sensi- 
tivity form (LSl) present in hearts maintained at a 
physiological calcium level. In Ca’+-free perfused 
hearts, part of the high sensitivity form (HS2) is 
converted into a low sensitivity form (LS2) by K+. 
These data are consistent with the hypothesis that 
the HS2 form is the in vitro representation of the 
inotropic site for ouabain in rat heart. 
2.1. Heart perfusions~ and isolation of highly- 
enriched sarcole~~a~ fra~t~~~ 
After killing the rats by cervical dislocation, the 
heart was removed and perfused with either a 
2 mM Ca’+-containing solution or a Ca2+-free 
medium [6]. We utilized the technique in 171. The 
left ventricle balloon volume was adjusted to pro- 
duce a normal diastolic pressure (- 18-22 mm fig). 
Hearts perfused with an ice-cold 2m mM Ca2”- 
containing solution exhibited a maximum pressure 
of 74 mm Hg compared to 100 mm Hg in control 
hearts at 37°C (table 1). Hearts perfused with the 
ice-cold Ca2+-free relaxing buffer rapidly stopped 
in diastole. (p= 25 mm Hg). From each type of 
heart, microsomes highly enriched in sarcolemmal 
vesicles were isolated as in [8]. To reveal latent 
enzyme activities, the vesicles were treated by 
repetitive freezings and thawings [6]. 
2.2. Estimation of Na’,K+-ATPase acfivity 
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The Na+,K+-ATPase activity was assayed as in 
[6] using 1Opg protein/ml incubation medium [9]. 
The sarcolemmal vesicles were preincubated with 
ouabain (Boehringer) for 30 min at 37°C with or 
without 10 mM KC1 in the assay medium contain- 
ing 4 mM MgClz, 100 mM NaCl and 40 mM 
Imidazole-HCl (pH 7.4). The reaction was then 
initiated with the addition of either ATP or ATP + 
KC1 (final con.: 4 or 4 and lOmM, respectively) 
and carried out over 6 time points to assess line- 
arity. Every minute, aliquots were taken and the 
released orthophosphate was measured [lo]. The 
Na+,K+-ATPase activities represented 50 f 10% of 
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the total ATPase activities. These assays in the 
presence of ATP, which favours ouabain binding 
[ll], were linear with respect to time, suggesting 
that the enzym~ouabain equilibrium was reached 
in <l min (the shortest time used). This is in full 
agreement with literature data [ 12-141, 
3. RESULTS 
The preparation we used were highly enriched in 
sarcolemmal vesicles, with specific activities of 
Na+,K+-ATPase varying between 86 + 15 and 
1002 lgpmol phosphate.h-‘.mg-” for hearts 
maintained at 2 mM Ca2+ and for Ca2+-free per- 
fused hearts, respectively. 
When native and opened vesicles from hearts 
maintained at a physiological calcium level were 
preincubated with ouabain in a K+-free medium, 
they exhibited a monophasic dose-response curve 
(fig. 1A). The ouabain concentration needed to 
half-maximally inhibit the activity (IGO) was 
3 f 0.7 x lo-$ M (table 2), a value consistent with 
earlier reports [l-3,6,12,15-17]. This value was 
not significantly modified by the addition of 
10 mM K+ to the preincubation medium, confirm- 
ing [17]. 
When native or opened vesicIes from hearts per- 
fused with a Ca’+-free buffer were preincubated in 
the presence of ouabain without K”, a ‘low con- 
centration inhibitory effect’ was observed between 
1O-q-1O-7 M ouabain (76 rt 11% inhibition). A 
residual ‘high concentration effect’ was completely 
Table 1 
Effects of perfusion of low or physiological calcium 
levels on maximum pressurea exhibited by isolated rat 
heart 
Perfusion OS 5s 10s 20s 60s 300~~ 
Ca” free 100 44 22 25 25 25 
2mM 96 38 44 62 64 74 
Prior to perfusion at 4”C, the heart was equilibrated for 
lo min as in [7] with Krebs-Ringer bicarbonate buffer at 
37OC. The control diastolic and systolic pressures were 
18-22 and 96400 mm Hg, respectively. Similar results 
were obtained with 6 hearts, the left ventricle diastolic 
pressure of which varying from 12-22 mm Hg: (a) 
maximum pressure, mm Hg at 4°C; (b) microsome 
preparation was initiated after 5 min perfusion. 
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Fig. 1. Dose-response curves of Na+,K+-ATPase 
activity versus ouabain concentrations in microsomes: 
(A) hearts maintained at 2mM Ca2+, microsomes 
preincubated without Kf (0) or with 1OmM K+ (ml; 
(B,C) Ca2+-free perfused hearts, microsomes preincu- 
bated without Kf (A) (B) or with 10mM K+ (0) (C) 
each experiment was performed 224 times with 24 
different preparations. Each point represents the mean 
of 8-18 obs., with bars denoting SED computed from 
percentage of inhibjtion in each experiment: (**) 
pco.01; (***) p<O.OOl). 
TabIe 2 
Effects of heart pretreatment and addition of K’ (10 mM) 
on the expression of the Na+,K+-ATPase forms. 
Preincu- 
bations 
Heart maintained 
at 2 mM Ca2+ 
Ca’+-free 
perfused 
heart 
Ouabain LS,(3i0.7X10-5M) HS2(1.5&0.3) 
Ouabain + KC LSr(3zk0.7X 1O-5 M) HS2(1.5rtO.3) 
+ LSzL 
a The progressive decline in residual activity did not 
allow ICSO determination 
In parentheses: ICSO values (x lo-’ M), ouabain 
concentrations to half-maximally inhibit the Na+,K+- 
ATPase form 
inhibited with LOW4 M ouabain (fig. 1B). The ap- 
parent IGO value could only be calculated for the 
highly sensitive form (HS2): 1.5 + 0.3 x 10T8 M 
(table 2). This concentration-response curve may 
represent two or more enzyme forms with very 
close apparent sensitivities. 
When K+ was present during preincubation, 
these vesicles clearly exhibited a biphasic dose- 
response curve with the high sensitivity form HS2 
associated with 63% f 13% of the total activity 
(fig. 1C). A progressive decline in residual activity 
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was found between 3 x lo-’ M and 3 x 10m4 M oua- 
bain (LS2). Since the total Na+,K+-ATPase activity 
remained constant whether or not K+ was present 
during preincubation, it may be assumed that this 
latter enzyme form (LS2) revealed by K+ was con- 
verted into the high sensitivity form (HS2) in the 
absence of K+. 
4. DISCUSSION 
Using rat hearts perfused with either physio- 
logical Ca2+ or Ca2+ -free buffers, we detected 3 
forms of Na+,K+-ATPase activities, two in hearts 
relaxed by Ca2+-free perfusion (HSz+ LS2) and 
one in hearts maintained at a physiological evel of 
calcium (LSi). The LS2 form was K’-dependent, 
whereas LSi was not. These 3 forms were related 
to the specific binding of ouabain during prein- 
cubation, since they were detected under identical 
assay conditions. The effects of K+ on the high 
sensitivity Na+,K+-ATPase activity were consis- 
tent with the effects of K+ on the inotropic action 
of ouabain [15]; i.e., no detectable change in the 
onset of inhibition induced by ouabain, but a 
decrease in the amplitude of the inhibition. The 
role of K+ on the relative proportion of HSz/LS2 
enzyme forms reported here agrees with the dif- 
ferential effects of K+ on the two [3H]ouabain 
receptor found in canine and guinea pig cardiac 
sarcolemma preparations [18,19]. Nevertheless, at 
low doses of ouabain (1O-8-1O-6 M), the degree of 
inhibition found here (63-76%) was dispropor- 
tionate to both the magnitude of the inotropic 
effect (up to 15%) [4,15] and to the low percentage 
(10%) of high affinity [ 3H]ouabain-binding sites 
found in rat cardiac sarcolemma preparations 
([l-3] unpublished). It is possible that our iso- 
lation procedure changed the properties of the 
enzyme by increasing the proportion of highly sen- 
sitive forms. Consistent with [20], this hypothesis 
was reinforced by our observation [6] that a dif- 
ferent membrane preparation procedure led to 
50% of the HS2 form (instead of 63-76%). The 
Ca2+-depletion, which in rat hepatocytes was 
found to stimulate the Na+,K+-pump [21] 2-fold 
may account for the high proportion of the HSz 
form. Due to the flexiblity of Na+/K+/ATP 
stoichiometry in the transport phenomenon at the 
cardiac level [5], the rate of ATP hydrolysis as an 
index of Na+, K+-ATPase activity may over- 
estimate the exact proportion of HS2 forms [18]. 
This supposes that it is the amount of ouabain- 
enzyme complex formed rather than the degree of 
enzyme inhibition which is the determining factor. 
The convergency of the two criteria, ouabain sen- 
sitivity (this work, [6]) and K+-dependency, both 
in vitro and in vivo, strengthens the hypothesis that 
part of the Na+,K+-ATPase activity in rat heart 
may also be the digitalis receptor in vivo, as it is in 
other species. 
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